« Previous
Next »
Diabetes Research and Clinical Practice
Volume 88, Issue 2
, Pages 171-176
, May 2010
Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes
References
- . Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 1999;340:115–126
- Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 2004;351:2599–2610
- Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn study. Arterioscler. Thromb. Vasc. Biol. 2006;26:1086–1093
- . Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J. Biol. Chem. 1996;271:24286–24293
- . Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int. 2000;58:1703–1710
- . Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67:291–300
- . Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42–47
- . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334
- Enhanced acutephase response and oxidative stress in older adults with type II diabetes. Horm. Metab. Res. 2000;32:407–412
- Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–2072
- Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998;41:185–192
- Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes. 1997;46:2075–2081
- Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care. 1998;21:1008–1013
- Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003;52:2586–2593
- Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005;28:2890–2985
- . Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 1996;125:653–657
- . Microalbuminuria and carotid artery intimamedia thickness in nondiabetic and NIDDM subjects: the insulin resistance atherosclerosis study (IRAS). Stroke. 1997;28:1710–1716
- . Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 2004;66:448–454
- . Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol. Dial. Transplant. 2008;23:919–926
- . Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 2006;344:780–785
- Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy. Arch. Med. Res. 2006;37:998–1003
- . Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin. Exp. Immunol. 1998;113:213–219
- Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 2006;99:69–77
- . Advanced glycation end products-cytokine–nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia. 1999;42:878–886
- Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism. 2003;52:605–608
- Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 1999;104:1041–1050
- European Renal cDNA Bank (ERCB) Consortium. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes. 2006;55:2993–3003
- . Chemokine expression in experimental tubulointerstitial nephritis. J. Immunol. 1997;159:870–876
- Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 2001;276:9945–9954
PII: S0168-8227(10)00015-X
doi: 10.1016/j.diabres.2010.01.012
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Diabetes Research and Clinical Practice
Volume 88, Issue 2
, Pages 171-176
, May 2010
